The NeuroCognitive Institute — Mount Arlington, New Jersey

The NeuroCognitive Institute is a clinical research site located in Mount Arlington, New Jersey, United States 07856.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

The NeuroCognitive Institute has participated in 14 clinical trials.

Therapeutic areas: Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Agitation in Participants With Dementia of the Alzheimer's Type, Alzheimer's Disease.

Sponsors: ACADIA Pharmaceuticals Inc., Otsuka Pharmaceutical Development & Commercialization, Inc., JANSSEN Alzheimer Immunotherapy Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The NeuroCognitive Institute?

The NeuroCognitive Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The NeuroCognitive Institute conducted?

The NeuroCognitive Institute has 14 clinical trials on record. Their work covers Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Agitation in Participants With Dementia of the Alzheimer's Type, Alzheimer's Disease.

Is The NeuroCognitive Institute accredited by Crixeo Health?

Yes — The NeuroCognitive Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The NeuroCognitive Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.